Prestige Consumer Healthcare
PBH
#3864
Rank
S$4.25 B
Marketcap
S$88.57
Share price
0.28%
Change (1 day)
-22.06%
Change (1 year)

EPS for Prestige Consumer Healthcare (PBH)

EPS in 2025 (TTM): S$5.36

According to Prestige Consumer Healthcare's latest financial reports the company's current EPS (TTM) is S$5.15. In 2024 the company made an earnings per share (EPS) of S$5.45 an increase over its 2023 EPS that were of S-$2.04.

EPS history for Prestige Consumer Healthcare from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S$5.36-1.71%
2024S$5.45-367.08%
2023S-$2.04-138.33%
2022S$5.3211.7%
2021S$4.7713.6%
2020S$4.20-651.67%
2019S-$0.76-148.78%
2018S$1.56-83.29%
2017S$9.33437.23%
2016S$1.74-34.13%
2015S$2.6452.94%
2014S$1.72-8.11%
2013S$1.88
2011S$1.10

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$14.12 174.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Procter & Gamble
PG
S$8.76 70.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$9.33 81.28%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$1.72-66.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$4.75-7.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Clorox
CLX
S$7.80 51.48%๐Ÿ‡บ๐Ÿ‡ธ USA
CVS Health
CVS
S$0.51-90.15%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$4.78-7.19%๐Ÿ‡ฌ๐Ÿ‡ง UK
Rite Aid
RAD
S-$37.55-829.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
S$1.55-69.95%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel